New drug candidate prevents preterm birth in preclinical studies
New research shows that Rytvela, an anti-inflammatory drug candidate, decreased premature birth and infant mortality when administered after the onset of preterm labor in a preclinical mouse model. The current standard treatment ...
Feb 24, 2026
0
6



